Benjamin Edwards’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.55M Sell
20,590
-3,456
-14% -$754K 0.04% 372
2026
Q2
$4.69M Sell
24,046
-1,222
-5% -$253K 0.04% 361
2026
Q1
$5.67M Sell
25,268
-823
-3% -$205K 0.06% 305
2025
Q4
$6.29M Sell
26,091
-4,365
-14% -$1.12M 0.07% 265
2025
Q3
$8.34M Sell
30,456
-905
-3% -$247K 0.09% 212
2025
Q2
$8.09M Sell
31,361
-1,039
-3% -$248K 0.1% 195
2025
Q1
$7.25M Sell
32,400
-2,883
-8% -$673K 0.1% 201
2024
Q4
$8.07M Sell
35,283
-741
-2% -$178K 0.12% 190
2024
Q3
$8.79M Buy
36,024
+35,626
+8,951% +$7.96M 0.13% 180
2024
Q2
$76K Buy
398
+100
+34% +$20.3K 0.01% 454
2024
Q1
$59K Buy
+298
New +$54.6K 0.01% 463

Other funds holding RMD

Benjamin Edwards's RMD Position: Q3 2026 in Review

Benjamin Edwards reduced its ResMed (RMD) stake by 14% in Q3 2026, selling an estimated $754K and leaving 20,590 shares worth $4.55M. The position accounts for 0.04% of the portfolio, ranked #372.

Benjamin Edwards first reported a position in RMD in Q1 2024 and has held it in 11 quarters since. The position peaked at $8.79M in Q3 2024. 741 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Benjamin Edwards held 20,590 shares of ResMed worth $4.55M as of Q3 2026.
  • Benjamin Edwards sold 3,456 ResMed shares in Q3 2026, an estimated $754K.
  • ResMed made up 0.04% of Benjamin Edwards's portfolio in Q3 2026, its #372 holding.
  • Benjamin Edwards first reported a position in ResMed in Q1 2024 and has held it in 11 quarters since.
  • Benjamin Edwards's ResMed position peaked at $8.79M in Q3 2024.
  • 741 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.